Fredric Cohen
Keine laufenden Positionen mehr
Karriereverlauf von Fredric Cohen
Ehemalige bekannte Positionen von Fredric Cohen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Aptalis Pharma LLC
 Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | Corporate Officer/Principal | 01.06.2009 | 01.03.2014 |
| Crownstone Group | Analyst-Equity | 01.07.2003 | 30.03.2006 |
| Direktor der Forschung - Eigenkapital | 01.07.2003 | 30.03.2006 | |
| Corporate Officer/Principal | 01.07.2003 | 30.03.2006 | |
| STRONGBRIDGE BIOPHARMA | Technik-/Wissenschafts-/F&E-Leiter | 18.11.2015 | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Ausbildung von Fredric Cohen
| Pennsylvania State University College of Medicine | Doctorate Degree |
| Franklin & Marshall College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Corporate Officer/Principal | 3 |
| Analyst-Equity | 1 |
| Director of Research - Equity | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Crownstone Group | Finance |
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
Aptalis Pharma LLC
Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | Health Technology |
- Börse
- Insiders
- Fredric Cohen
- Erfahrung
